Fig. 2From: Mixed adenoneuroendocrine carcinoma with loss of HER2 positivity after trastuzumab-based chemotherapy for HER2-positive gastric cancer: a case reportComputed tomography findings. Imaging before chemotherapy revealed thickening in the wall of the stomach and ring-enhanced liver metastases (100 mm and 105 mm in diameter). a Axial. b Coronal. Imaging after chemotherapy revealed that the stomach tumor and liver metastases had shrunken considerably. c Axial. d CoronalBack to article page